Chapter 30: Epidemiology and Public Health

Epidemiology examines the occurrence, distribution, and determinants of disease, allowing scientists and public health officials to track disease transmission, identify sources of infection, and implement control strategies. Key epidemiological measurements include incidence, which represents the number of new disease cases within a specific time period, and prevalence, which reflects the total number of existing and new cases in a population. Infectious diseases can be categorized according to their patterns of occurrence, including endemic diseases that persist within a population, epidemics characterized by rapid increases in disease cases, and pandemics that spread globally. The progression of acute infectious disease typically follows stages including infection, incubation, acute illness, decline, and recovery. Epidemiologists also measure disease burden using metrics such as morbidity, mortality, and disability adjusted life years to assess the societal impact of disease. Transmission of pathogens occurs through multiple routes including direct or indirect person to person contact, airborne droplets, contaminated environmental sources known as vehicles, or living vectors such as arthropods. Disease reservoirs and asymptomatic carriers play important roles in maintaining and spreading pathogens within populations. The dynamics of disease transmission are influenced by pathogen virulence and by the basic reproduction number, which estimates how many new infections arise from a single infected individual. Population level immunity, particularly herd immunity generated through vaccination or prior exposure, can interrupt transmission chains and reduce outbreak potential. Public health systems use surveillance programs, vaccination campaigns, sanitation measures, isolation, quarantine, and international monitoring organizations to control infectious disease spread. The chapter also discusses emerging and reemerging diseases influenced by environmental changes, global travel, antibiotic resistance, and public health infrastructure challenges, as well as the threat of microbial bioterrorism and the need for coordinated global disease preparedness and response.